Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Knee Cartilage Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Knee Osteoarthritis Epidemiology Analysis
5.1 Epidemiology Overview (2019-2035)
5.2 North America Knee Osteoarthritis Epidemiology (2019-2035)
5.3 Europe Knee Osteoarthritis Epidemiology (2019-2035)
5.4 Asia-Pacific Knee Osteoarthritis Epidemiology (2019-2035)
5.5 Latin America Knee Osteoarthritis Epidemiology (2019-2035)
5.6 Middle East & Africa Knee Osteoarthritis Epidemiology (2019-2035)
6 Global Knee Cartilage Repair Market Overview
6.1 Global Knee Cartilage Repair Market Historical Value (2019-2025)
6.2 Global Knee Cartilage Repair Market Forecast Value (2026-2035)
7 Global Knee Cartilage Repair Market Landscape
7.1 Knee Cartilage Repair: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Knee Cartilage Repair: Product Landscape
7.2.1 Analysis by Treatment Modality
7.2.2 Analysis by Surgery
7.2.3 Analysis by Devices
7.2.4 Analysis by Application
7.2.5 Analysis by End User
8 Knee Cartilage Repair Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Knee Cartilage Repair Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Knee Cartilage Repair Market Segmentation
11.1 Global Knee Cartilage Repair Market by Treatment Modality
11.1.1 Market Overview
11.1.2 Cell-based
11.1.2.1 Chondrocyte Transplantation
11.1.2.2 Growth Factor Technology
11.1.3 Noncell- Based
11.1.3.1 Tissue Scaffolds
11.1.3.2 Cell-Free Composites
11.2 Global Knee Cartilage Repair Market by Surgery
11.2.1 Market Overview
11.2.1.1 Osteochondral Autograft Transplantation
11.2.1.2 Osteochondral Allograft Transplantation
11.2.1.3 Microfracture
11.2.1.4 Drilling
11.2.1.5 Abrasion Arthroplasty
11.2.1.6 Autologous Chondrocyte Implantation
11.2.1.7 Others
11.3 Global Knee Cartilage Repair Market by Devices
11.3.1 Market Overview
11.3.2 Implants
11.3.3 Osteotomy
11.3.4 Bone Grafts
11.3.5 Arthroscopy
11.3.6 Resurfacing
11.3.7 Arthrodesis
11.3.8 Others
11.4 Global Knee Cartilage Repair Market by Application
11.4.1 Market Overview
11.4.2 Osteoarthritis
11.4.3 Rheumatoid Arthritis
11.4.4 Osteonecrosis
11.4.5 Fractures
11.4.6 Bone Tumors
11.4.7 Others
11.5 Global Knee Cartilage Repair Market by End User
11.5.1 Market Overview
11.5.2 Hospitals
11.5.3 Orthopedic Centres
11.5.4 Ambulatory Surgical Centres
11.5.5 Others
11.6 Global Knee Cartilage Repair Market by Region
11.6.1 Market Overview
11.6.2 North America
11.6.3 Europe
11.6.4 Asia Pacific
11.6.5 Latin America
11.6.6 Middle East and Africa
12 North America Knee Cartilage Repair Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Knee Cartilage Repair Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Knee Cartilage Repair Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Knee Cartilage Repair Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Knee Cartilage Repair Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Stryker
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Zimmer Biomet
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 B. Braun Melsungen AG
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 The Future of Biotechnology
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 MEDIPOST
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Vericel Corporation
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 CONMED Corporation
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Meril Life Sciences Pvt. Ltd.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Medacta International
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Teijin Nakashima Medical Co., Ltd.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 EVOLUTIS INDIA PVT. LTD.
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Regentis Biomaterials Ltd.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Auxein Medical.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
24 Knee Cartilage Repair - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*